Veritas to Buy Thomson Reuters Healthcare Business for $1.25B

Veritas Capital has agreed to acquire Thomas Reuters’ (NYSE: TRI) healthcare business for $1.25 billion cash, the companies announced Monday. The companies expect the transaction to close within the next few months. The acquisition aligns with Veritas’ goal of expanding its healthcare analytics offerings, said Chairman Robert McKeon. Mike Boswood, president of the healthcare business, will...